Idexx Laboratories Inc (IDXX)

Date: O: H: L: C: Vol:

Finanzdaten der Idexx Laboratories Inc-Aktie (IDXX)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	6.64%1,216.59	1,140.82	1,090.58	1,105.24	1,109.46
Cost Of Revenue	4.64%437.50	418.08	432.47	421.89	414.73
Gross Profit	7.80%779.09	722.74	658.11	683.35	694.73
	1.84%353.52	360.15	342.51	328.51	321.69
Research and Development	0.55%65.43	65.79	66.83	63.42	61.90
Provision For Loan, Lease, And Other Losses	40.84%2.33	3.94	2.45	1.62	1.47
Operating Income/Loss	17.37%425.57	362.59	315.61	354.85	373.05
Income/Loss From Continuing Operations Before Tax	17.38%417.22	355.44	306.98	344.77	293.99
Income Tax Expense/Benefit	2.36%78.81	77.00	58.79	70.16	68.36
	21.54%338.41	278.45	248.19	274.61	293.99
Attributable To Parent	21.54%338.41	278.45	248.19	274.61	293.99
Basic Average Shares	0.87%78.95	79.65	-0.18	80.10	80.41
Diluted Average Shares	1.06%79.31	80.16	-0.18	80.68	80.99
Basic Earnings Per Share	22.57%4.29	3.50	3.11	3.43	3.66
Diluted Earnings Per Share	23.05%4.27	3.47	3.09	3.40	3.63